Jan Hansen
University of Washington · Pharmacy
Active 1967–2023
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Jan Hansen is an Affiliate Associate Professor and the Global Head of Health Economics and Value Assessment in the Specialty Care division at Sanofi. He holds a Doctor of Philosophy (PhD) in Pharmacy Administration and Pharmacy Policy from the University of South Carolina and a Bachelor of Science in Pharmacy from the University of Iowa. He is affiliated with the Department of Pharmacy at the University of Washington's School of Pharmacy. His research focuses on health economics and value assessment within the pharmaceutical and healthcare sectors. Hansen's expertise includes evaluating the economic impact of healthcare interventions and contributing to the development of value-based approaches in specialty care. His professional background combines academic training with industry experience, positioning him as a leader in health economics and policy within the pharmaceutical industry.
Research topics
- Medicine
- Internal medicine
- Oncology
- Immunology
- Biology
- Genetics
Selected publications
eLife · 2018-08-28 · 158 citations
articleOpen accessThe T cell receptor (TCR) repertoire encodes immune exposure history through the dynamic formation of immunological memory. Statistical analysis of repertoire sequencing data has the potential to decode disease associations from large cohorts with measured phenotypes. However, the repertoire perturbation induced by a given immunological challenge is conditioned on genetic background via major histocompatibility complex (MHC) polymorphism. We explore associations between MHC alleles, immune expos…
Blood · 2017-03-08 · 92 citations
articleOpen accessSenior author), with hazard ratios ranging from 1.2 to 3.29. Underlying genetic differences can influence development of IA following HCT. Identification of genetic predispositions to IA could have important implications in donor screening, risk stratification of recipients, monitoring, and prophylaxis.
Blood · 2017-06-09 · 83 citations
articleOpen access= .001-.040). Inherited ciHHV-6 status did not significantly affect risk for chronic GVHD, hematopoietic cell engraftment, overall mortality, or nonrelapse mortality. Screening for iciHHV-6 could guide donor selection and post-HCT risk stratification and treatment. Further study is needed to replicate these findings and identify potential mechanisms.
Association of Plasma CD163 Concentration with De Novo–Onset Chronic Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation · 2017-04-25 · 50 citations
articleOpen accessSenior authorBiology of Blood and Marrow Transplantation · 2017-05-03 · 34 citations
articleOpen accessSenior author
Recent grants
NIH · $20.8M · 2015
Adult Leukemia Research Center
NIH · $288.7M · 1997–2029
NIH · $4.1M · 2010
Frequent coauthors
- 721 shared
Paul J. Martin
University of Washington
- 329 shared
Effie W. Petersdorf
Fred Hutch Cancer Center
- 324 shared
Claudio Anasetti
Moffitt Cancer Center
- 297 shared
Eric Mickelson
- 208 shared
Rainer Storb
University of Washington
- 190 shared
Barry E. Storer
- 183 shared
Anajane G. Smith
The University of Texas at Arlington
- 181 shared
Frederick R. Appelbaum
Fred Hutch Cancer Center
Labs
Lee LabPI
Education
Ph.D., Pharmacy Administration and Pharmacy Policy
University of South Carolina
B.S., Pharmacy
University of Iowa
Similar researchers at University of Washington
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Jan Hansen
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup